thalidomide has been researched along with Esophagotracheal Fistula in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gourevitch, A | 1 |
| Myers, EN | 1 |
| Stoll, S | 1 |
| Weltschew, A | 1 |
2 other studies available for thalidomide and Esophagotracheal Fistula
| Article | Year |
|---|---|
Duodenal atresia in the newborn.
Topics: Animals; Bile Ducts; Dehydration; Duodenal Obstruction; Duodenum; Gastrointestinal Motility; Humans; | 1971 |
Congenital anomaly of the middle and inner ear.
Topics: Abnormalities, Drug-Induced; Cleft Lip; Cleft Palate; Ear, Inner; Ear, Middle; Humans; Infant; Male; | 1968 |